Dennis Schrijnders

5PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Information systems development methodologies and practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 15, 2020
Is Gliclazide Associated with a Lower Obesity-Related Cancer Risk Compared to Other Sulfonylureas? A Long-term Prospective Cohort Study.

Jing Du, Nanno Kleefstra, Dennis Schrijnders

|Jan 26, 2018
Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49).

Dennis Schrijnders, Steven H Hendriks, Nanne Kleefstra

|Jun 25, 2017
Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) - a study protocol.

Dennis Schrijnders, Geertruida H de Bock, Sebastiaan T Houweling

|Jun 22, 2016
Within-Sulfonylurea-Class Evaluation of Time to Intensification with Insulin (ZODIAC-43).

Dennis Schrijnders, Laura C Hartog, Nanne Kleefstra

Pageof 1